US STOCK
DXCM Stock Analysis
US stocks · market data · technical indicators
DexCom, Inc.
DXCMUS stocksQuote delayed 15 min
9/12 上午12:13 updated
$83.40
-1.12-1.32%
Open
$84.65
High
$85.82
Low
$83.03
Volume
62.38萬
DXCM price history
-8.84%Open
91.48
Latest
83.39
High
92.34
Low
83.39
Average
88.86
Advertisement
AI Composite Technical Analysis
BetaFormula: fundamentals (40%) + technical indicators (30%) + market sentiment (30%)
AI Score60
Score range 0–100; a higher score indicates a stronger buy signal
Market Status
HoldCurrent Price$83.395
Target Price$91.735
Change %-1.32%
Institutional
Net Buying
Foreign Ownership
Reducing
Market Heat
Cautious
Fundamentals (US)
P/E Ratio
32.82x
ROE
38.49%
P/B Ratio
11.95x
Dividend Yield
--
Market Insight
The score sits in neutral territory (60/100). Waiting for a clearer signal may be warranted. Return on equity of 38.49% indicates solid profitability. The target price implies roughly 10.00% upside.
This analysis is for reference only and does not constitute investment advice. Investing carries risk; educational content only.
Financial snapshot
DXCM - DexCom, Inc.
EPS
2.53USD
Forward EPS
3.12USD
P/E
32.82x
Forward P/E
26.58x
P/B
11.95x
ROE
38.49%
ROA
10.33%
Operating margin
24.33%
Profit margin
20.12%
Revenue growth
13.10%
Earnings growth
43.60%
Dividend yield
--
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| Revenue | $1.31B | $1.19B | $1.26B | $1.21B | $1.16B |
| Gross profit | $830.00M | $750.30M | $792.70M | $731.40M | $688.80M |
| Operating income | $318.30M | $255.30M | $323.00M | $242.50M | $212.60M |
| Net income | $249.10M | $199.50M | $267.30M | $283.80M | $179.80M |
| Basic EPS | 0.65 | 0.52 | 0.69 | 0.73 | 0.46 |
| Diluted EPS | 0.64 | 0.51 | 0.68 | 0.70 | 0.45 |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| BlackRock Inc. | 2024-06-30 | $3.9B | 0.09% |
| VANGUARD GROUP INC | 2025-12-31 | $3.3B | 0.05% |
| STATE STREET CORP | 2026-06-30 | $1.2B | 0.04% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $109.8M | 0.15% |
| CITADEL ADVISORS LLC | 2026-06-30 | $81.6M | 0.01% |
| Bridgewater Associates, LP | 2026-06-30 | $27M | 0.11% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $3.1M | 0.00% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$94.12
Target range
$79.00 – $115.00
Implied upside
13.36%
Strong buy
3
Buy
22
Hold
3
Sell
0
Strong sell
0
Advertisement